Christopher T. Cox
2016
In 2016, Christopher T. Cox earned a total compensation of $4.3M as Chief Corporate Development Officer at Medicines.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $266,993 |
| Option Awards | $3,500,009 |
| Salary | $422,436 |
| Other | $9,445 |
| Total | $4,298,883 |
Cox received $3.5M in option awards, accounting for 81% of the total pay in 2016.
Cox also received $100K in bonus, $267K in non-equity incentive plan, $422.4K in salary and $9.4K in other compensation.
Rankings
In 2016, Christopher T. Cox's compensation ranked 2,000th out of 14,075 executives tracked by ExecPay. In other words, Cox earned more than 85.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,000 out of 14,075 | 86th |
Division Manufacturing | 683 out of 5,486 | 88th |
Major group Chemicals And Allied Products | 194 out of 1,900 | 90th |
Industry group Drugs | 138 out of 1,543 | 91st |
Industry Pharmaceutical Preparations | 111 out of 1,173 | 91st |
Source: SEC filing on April 26, 2017.
Cox's colleagues
We found four more compensation records of executives who worked with Christopher T. Cox at Medicines in 2016.